Amgen
Tracked across 8 events · 52 articles · First seen Dec 19, 2025 · Last active Jun 30, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Amgen voluntarily recalled nearly one million bottles of its Corlanor and Sensipar tablets due to the presence of a foreign substance, impacting its product distribution and potentially its reputation, though the health risk is deemed low.
Jun 27, 2026 · 6 articles
Regulatory
Impact: Amgen acquired ChemoCentryx in 2022, and as such, the revocation of the EU marketing authorization for TAVNEOS, a drug developed by ChemoCentryx, will have an indirect negative impact on Amgen.
Jun 26, 2026 · 9 articles
Regulatory
Impact: Amgen is one of the leading life sciences companies that has established or expanded R&D, digital, and global capability centers in Hyderabad, reflecting confidence in India — Telangana's ecosystem.
Jan 21, 2026 · 6 articles
Business
Impact: Rajani Dinavahi spent seven years at Amgen, contributing to multiple global development programs.
Apr 01, 2026 · 6 articles
Tech
Impact: One author disclosed ties to Amgen, which is a minor detail in the context of the overall study findings.
Jun 15, 2026 · 6 articles
100
Amgen recalled bottlesAmgen Recalls Corlanor,...
ERGEN INTELLIGENCE
Track Amgen live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard